NCT01985763View on ClinicalTrials.gov

Genistein in Treatment of Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 19, 2017

Study Completion Date

October 31, 2018

Conditions
Colon CancerRectal CancerColorectal Cancer
Interventions
DRUG

Genistein

Genistein combined with FOLFOX or FOLFOX-Avastin

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Sofya Pintova

OTHER

NCT01985763 - Genistein in Treatment of Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter